BioEdgeCRISPR on the rampageBioEdgeCRISPR on the rampage. by Michael Cook | 14 Apr 2018 | Link. CRISPR gene editing is one of the most exciting technologies of recent years, although most of the excitement so far involves curing people of obscure disea… Continue reading
BioEdgeCRISPR on the rampageBioEdgeCRISPR on the rampage. by Michael Cook | 14 Apr 2018 | Link. CRISPR gene editing is one of the most exciting technologies of recent years, although most of the excitement so far involves curing people of obscure disea… Continue reading
Bone marrow and stem cell drive next weekAlpena NewsThere will be a bone marrow and stem cell drive from 9 a.m.-5 p.m. Thursday at the Alpena Community College Besser Technical Center room 109. Event organizer Emily Lozen said she started the event aft… Continue reading
Bone marrow and stem cell drive next weekAlpena NewsThere will be a bone marrow and stem cell drive from 9 a.m.-5 p.m. Thursday at the Alpena Community College Besser Technical Center room 109. Event organizer Emily Lozen said she started the event aft… Continue reading
Barron’sAveXis Sale: An $8.7 Billion Endorsement for Gene TherapyBarron’sReview | Preview. Last Monday may have been validation day for replacement gene therapy—a promising biotechnology treatment for some diseases that substitutes healthy genes for di… Continue reading
Targeted OncologyAdoptive Immunotherapy Makes Inroads in Head and Neck Cancers, But Challenges RemainTargeted OncologyEarly data on adoptive immunotherapy in head and neck cancers have shown just modest responses. However, they provide proof-of-concept… Continue reading
Targeted OncologyAdoptive Immunotherapy Makes Inroads in Head and Neck Cancers, But Challenges RemainTargeted OncologyEarly data on adoptive immunotherapy in head and neck cancers have shown just modest responses. However, they provide proof-of-concept… Continue reading
NMSU Herald |
Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy
GenomeWeb “Through our deep understanding of cancer biology and emerging research, we recognize the importance for physicians to know each patient’s biomarker status to help fight their cancer in a more personalized way,” Saurabh Saha, senior vice president … Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion …Markets Insider Bristol Partners With Illumina On Diagnostic Test To Use With OpdivoForbes |